电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) (AA 399-411) 抗体

This anti- antibody is a 兔 多克隆 antibody detecting in WB. Suitable for SARS Coronavirus (SARS-CoV).
产品编号 ABIN960911
发货至: 中国

Quick Overview for SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) (AA 399-411) 抗体 (ABIN960911)

抗原

See all SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) 抗体
SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)

适用

  • 15
  • 7
  • 4
  • 2
  • 1
SARS Coronavirus (SARS-CoV)

宿主

  • 12
  • 11
  • 1

克隆类型

  • 15
  • 9
多克隆

标记

  • 23
  • 1
非结合性

应用范围

  • 21
  • 17
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
Western Blotting (WB)
  • 抗原表位

    • 1
    • 1
    • 1
    • 1
    AA 399-411

    特异性

    Recognizes SARS, Nucleocapsid Protein (Severe Acute Respiratory Syndrome).

    纯化方法

    Purified

    免疫原

    Synthetic peptides corresponding to amino acids 399-411 of putative SARS nucleocapsid (Genbank accession no. NP_828858).

    Type of Immunogen: Synthetic peptide

    亚型

    IgG
  • 应用备注

    Approved: WB (1:100 - 1:2000)

    Usage: Suitable for the detection of SARS Nucleocapsid protein in western blot analysis. It can also be used in cell staining. Western blot analysis of SARS Nucleocapsid in (A) untransfected mouse melanoma cell lysate and (B) transfected cell lysate using antibody at a 1:2000 dilution. Western blot: 1:100-1:2000.

    说明

    Target Species of Antibody: SARS Coronavirus

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    Lot specific

    缓冲液

    PBS, 0.2 % gelatin, 0.05 % sodium azide.

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • 抗原

    SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)

    别名

    SARS Nucleocapsid Protein

    物质类

    Viral Protein

    背景

    Name/Gene ID: N
    Family: Virion Structure

    Synonyms: N, SARS-NCP

    基因ID

    1489678

    NCBI登录号

    NP_828858
You are here:
Chat with us!